286 related articles for article (PubMed ID: 29150426)
1. Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury.
Chapman AR; Shah ASV; Lee KK; Anand A; Francis O; Adamson P; McAllister DA; Strachan FE; Newby DE; Mills NL
Circulation; 2018 Mar; 137(12):1236-1245. PubMed ID: 29150426
[TBL] [Abstract][Full Text] [Related]
2. High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome.
Miller-Hodges E; Anand A; Shah ASV; Chapman AR; Gallacher P; Lee KK; Farrah T; Halbesma N; Blackmur JP; Newby DE; Mills NL; Dhaun N
Circulation; 2018 Jan; 137(5):425-435. PubMed ID: 28978551
[TBL] [Abstract][Full Text] [Related]
3. High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction.
Chapman AR; Adamson PD; Shah ASV; Anand A; Strachan FE; Ferry AV; Lee KK; Berry C; Findlay I; Cruikshank A; Reid A; Gray A; Collinson PO; Apple F; McAllister DA; Maguire D; Fox KAA; Vallejos CA; Keerie C; Weir CJ; Newby DE; Mills NL;
Circulation; 2020 Jan; 141(3):161-171. PubMed ID: 31587565
[TBL] [Abstract][Full Text] [Related]
4. High sensitivity-troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: An examination against criteria of causality.
Chew DP; Briffa TG; Alhammad NJ; Horsfall M; Zhou J; Lou PW; Coates P; Scott I; Brieger D; Quinn SJ; French J
Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):419-28. PubMed ID: 25505224
[TBL] [Abstract][Full Text] [Related]
5. High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome.
Bularga A; Lee KK; Stewart S; Ferry AV; Chapman AR; Marshall L; Strachan FE; Cruickshank A; Maguire D; Berry C; Findlay I; Shah ASV; Newby DE; Mills NL; Anand A
Circulation; 2019 Nov; 140(19):1557-1568. PubMed ID: 31475856
[TBL] [Abstract][Full Text] [Related]
6. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Prognosis of Myocardial Injury, Type 1, and Type 2 Myocardial Infarction in the Emergency Unit.
Putot A; Derrida SB; Zeller M; Avondo A; Ray P; Manckoundia P; Cottin Y
Am J Med; 2018 Oct; 131(10):1209-1219. PubMed ID: 29753793
[TBL] [Abstract][Full Text] [Related]
8. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
Nikorowitsch J; Borchardt T; Appelbaum S; Ojeda F; Lackner KJ; Schnabel RB; Blankenberg S; Zeller T; Karakas M
J Am Heart Assoc; 2020 Apr; 9(8):e015452. PubMed ID: 32299288
[TBL] [Abstract][Full Text] [Related]
9. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
10. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
[TBL] [Abstract][Full Text] [Related]
11. Late Outcomes of Patients With Prehospital ST-Segment Elevation and Appropriate Cardiac Catheterization Laboratory Nonactivation.
Faour A; Pahn R; Cherrett C; Gibbs O; Lintern K; Mussap CJ; Rajaratnam R; Leung DY; Taylor DA; Faddy SC; Lo S; Juergens CP; French JK
J Am Heart Assoc; 2022 Jul; 11(13):e025602. PubMed ID: 35766276
[TBL] [Abstract][Full Text] [Related]
12. Risk Estimation in Type 2 Myocardial Infarction and Myocardial Injury: The TARRACO Risk Score.
Cediel G; Sandoval Y; Sexter A; Carrasquer A; González-Del-Hoyo M; Bonet G; Boqué C; Schulz K; Smith SW; Bayes-Genis A; Apple FS; Bardaji A
Am J Med; 2019 Feb; 132(2):217-226. PubMed ID: 30419227
[TBL] [Abstract][Full Text] [Related]
13. Different Causes of Death in Patients with Myocardial Infarction Type 1, Type 2, and Myocardial Injury.
Lambrecht S; Sarkisian L; Saaby L; Poulsen TS; Gerke O; Hosbond S; Diederichsen ACP; Thygesen K; Mickley H
Am J Med; 2018 May; 131(5):548-554. PubMed ID: 29274756
[TBL] [Abstract][Full Text] [Related]
14. Clinical Relevance of Cardiac Troponin Assessment in Patients Undergoing Carotid Endarterectomy.
Grobben RB; Vrijenhoek JE; Nathoe HM; Den Ruijter HM; van Waes JA; Peelen LM; van Klei WA; de Borst GJ
Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):473-80. PubMed ID: 26553374
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
16. Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome.
Chapman AR; Lee KK; McAllister DA; Cullen L; Greenslade JH; Parsonage W; Worster A; Kavsak PA; Blankenberg S; Neumann J; Sörensen NA; Westermann D; Buijs MM; Verdel GJE; Pickering JW; Than MP; Twerenbold R; Badertscher P; Sabti Z; Mueller C; Anand A; Adamson P; Strachan FE; Ferry A; Sandeman D; Gray A; Body R; Keevil B; Carlton E; Greaves K; Korley FK; Metkus TS; Sandoval Y; Apple FS; Newby DE; Shah ASV; Mills NL
JAMA; 2017 Nov; 318(19):1913-1924. PubMed ID: 29127948
[TBL] [Abstract][Full Text] [Related]
17. The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention.
Milani RV; Fitzgerald R; Milani JN; Lavie CJ
Catheter Cardiovasc Interv; 2009 Nov; 74(6):819-22. PubMed ID: 19670308
[TBL] [Abstract][Full Text] [Related]
18. Troponin rise in hospitalized patients with nonacute coronary syndrome: retrospective assessment of outcomes and predictors.
Dhesi S; Shanks M; Tymchak WJ
Can J Cardiol; 2015 Mar; 31(3):296-301. PubMed ID: 25746021
[TBL] [Abstract][Full Text] [Related]
19. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Chia S; Senatore F; Raffel OC; Lee H; Wackers FJ; Jang IK
JACC Cardiovasc Interv; 2008 Aug; 1(4):415-23. PubMed ID: 19463339
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of unrecognised myocardial infarction determined by electrocardiography or cardiac magnetic resonance imaging: systematic review and meta-analysis.
Yang Y; Li W; Zhu H; Pan XF; Hu Y; Arnott C; Mai W; Cai X; Huang Y
BMJ; 2020 May; 369():m1184. PubMed ID: 32381490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
